Latest News

Record Q3 results and raised full-year guidance across all metrics.

Record Q3 results driven by data center AI momentum and industrial market recovery.

Revenue grew 12% as newer products like CASGEVY and JOURNAVX ramped up significantly.

The enterprise value of the monster deal was estimated at almost $49 billion.

IonQ's revenue rose 287% and Rigetti's 185% last quarter, but both carry steep valuations. Here's how the two compare on risk and fit.

The company's shift to enterprise workflows over generic productivity tools reveals why its pricing power may compound as corporate adoption accelerates.

Production grew 6% as debt fell $500 million, signaling improved momentum.

Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.

Lymphedema revenue surged 13% as Medicare prior authorization stabilized.

Redemption revenue surged 23% as publisher network hit all-time high redeemers.

While AI and memory stocks get hammered on bubble fears, these three companies just posted sold-out demand, record revenue, and raised guidance.

Tinder DAU returns to growth after 3.5 years; Hinge revenue surges 19% YoY.

AI initiatives and higher-value clients drive $185.6M revenue amid marketplace pressures.

Record revenue surged 151% year-over-year as both distribution channels scaled rapidly.

Procedure volume surged 20% as active physicians hit record 1,770.

Reimbursement headwinds cut Q3 revenue, but 2027 outlook improves.

Revenue surged 37% year-over-year as margins expanded and earnings doubled sequentially.

I-Mab (NASDAQ:NBP) presented updated Phase 1b data for givastomig, an investigational treatment being developed for frontline metastatic gastric and gastroesophageal cancer, citing longer follow-up that the company said strengthened its confidence in the therapy’s durability, safety profile and pote

The company is making yet another acquisition.

Data center revenue surged 78% as Fabrinet expands capacity.

Revenue fell 12% as Gaia prioritizes high-value direct subscribers over volume.

Subscription bookings surged 34% as AI capabilities drove adoption gains.

FILSPARI sales hit $200.2 million as FSGS launches alongside sustained IgAN demand.

Revenue surged 52% as operating margins expanded 1,300 basis points year over year.

AI data center revenue surged 175% year over year as supply constraints redirected capacity.